Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

被引：0
|
作者：
Ami N. Shah
Justin M. Summy
Jing Zhang
Serk In Park
Nila U. Parikh
Gary E. Gallick
机构：
[1] University of Texas M.D. Anderson Cancer Center,Department of Surgical Oncology
[2] University of Texas M.D. Anderson Cancer Center,Department of Cancer Biology
来源：
Annals of Surgical Oncology | 2007年 / 14卷
关键词：
Pancreatic cancer; EMT; Gemcitabine chemoresistance; c-Met; Cancer stem cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3629 / 3637
页数：8
相关论文
共 50 条
  • [21] Mechanisms of metformin's anti-tumor activity against gemcitabine-resistant pancreatic adenocarcinoma
    Suzuki, Keiichi
    Takeuchi, Osamu
    Suzuki, Yukio
    Kitagawa, Yuko
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (02) : 764 - 772
  • [22] Upregulation of integrin-linked kinase enhances tumor progression in gemcitabine-resistant pancreatic cancer
    Murase, Hiromichi
    Matsuo, Yoichi
    Denda, Yuki
    Nonoyama, Keisuke
    Kato, Tomokatsu
    Aoyama, Yoshinaga
    Hayashi, Yuichi
    Imafuji, Hiroyuki
    Saito, Kenta
    Morimoto, Mamoru
    Ogawa, Ryo
    Takahashi, Hiroki
    Mitsui, Akira
    Kimura, Masahiro
    Takiguchi, Shuji
    ONCOLOGY REPORTS, 2023, 50 (03)
  • [23] Mass Spectrometry-Based Metabolic Profiling of Gemcitabine-Sensitive and Gemcitabine-Resistant Pancreatic Cancer Cells
    Fujimura, Yoshinori
    Ikenaga, Naoki
    Ohuchida, Kenoki
    Setoyama, Daiki
    Irie, Miho
    Miura, Daisuke
    Wariishi, Hiroyuki
    Murata, Masaharu
    Mizumoto, Kazuhiro
    Hashizume, Makoto
    Tanaka, Masao
    PANCREAS, 2014, 43 (02) : 311 - 318
  • [24] Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity
    Yan-qiu Ou
    Wen-bo Zhu
    Yan Li
    Peng-xin Qiu
    Yi-jun Huang
    Jun Xie
    Song-min He
    Xiao-ke Zheng
    Tian-dong Leng
    Dong Xu
    Guang-mei Yan
    Acta Pharmacologica Sinica, 2010, 31 : 73 - 80
  • [25] Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity
    Ou, Yan-qiu
    Zhu, Wen-bo
    Li, Yan
    Qiu, Peng-xin
    Huang, Yi-jun
    Xie, Jun
    He, Song-min
    Zheng, Xiao-ke
    Leng, Tian-dong
    Xu, Dong
    Yan, Guang-mei
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (01) : 73 - 80
  • [26] Gemcitabine-resistant pancreatic cancer: a second-line option
    Oettle, Helmut
    Lehmann, Thorsten
    LANCET, 2016, 387 (10018): : 507 - 508
  • [27] Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells
    Lin, Ji-Hua
    Chen, Sheng-Yi
    Lu, Chi-Cheng
    Lin, Jer-An
    Yen, Gow-Chin
    PHYTOTHERAPY RESEARCH, 2020, 34 (08) : 2053 - 2066
  • [28] Dissecting the transcriptomic changes of gemcitabine-resistant cholangiocarcinoma cells
    Intuyod, Kitti
    Pinlaor, Somchai
    Pairojkul, Chawalit
    Chomwong, Sasitorn
    Thongpon, Phonpilas
    Pongking, Thatsanapong
    CANCER SCIENCE, 2023, 114 : 678 - 678
  • [29] Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
    Zhou, Yunjiang
    Zhou, Yang
    Yang, Mengdi
    Wang, Keke
    Liu, Yisi
    Zhang, Mingda
    Yang, Yunjia
    Jin, Chenyu
    Wang, Rui
    Hu, Rong
    REDOX BIOLOGY, 2019, 22
  • [30] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (03): : 288 - 289
12345